Matching Categories

Search results found in:
 
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > Middle East > United Arab Emirates
Category: All Categories > Life Sciences > Pharmaceuticals > Diseases & Conditions
(5 reports matching your criteria)
 
Calming and Sleeping in the United Arab Emirates
2/4/2013 | published by: Euromonitor International
... and Librax are widely available under-the-counter from chemists/pharmacies. As the country’s economic situation improved in 2011, many consumers traded up from OTC to Rx products, viewing the latter as offering greater efficacy. Euromonitor International's Calming ...  |  read more...
$900.00
UAE Healthcare Sector Forecast to 2012
11/1/2011 | published by: RNCOS
... diseases (obesity, diabetes, and hypertension), epidemic outbreaks like H1N1, and the lack of internationally accredited healthcare infrastructure. According to our new research report, "UAE Healthcare Sector Forecast to 2012", the UAE healthcare industry is expected ...  |  read more...
$1,000.00
Diabetes Market in UAE
2/1/2011 | published by: RNCOS
... 300 Million diabetics worldwide. Similarly, the prevalence of diabetes has been increasing in the UAE as well. Diabetes in the UAE is becoming a major health issue with 19-25% of the UAE nationals or one ...  |  read more...
$800.00
Calming and Sleeping - United Arab Emirates
4/30/2010 | published by: Euromonitor International
... to opt for prescription medication, believing this to be more effective than over the counter alternatives. Growth in this category though registered at a current value of 4% compared to a review period value CAGR ...  |  read more...
$900.00
Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia Growth opportunities in fragmented markets
12/19/2008 | published by: Datamonitor
... diabetes markets in the GCC; including the impact of regulatory processes such as the healthcare reforms currently being undertaken. Scope Description and analysis of the uniqueness of the antidiabetic markets in the UAE and Saudi ...  |  read more...
$3,800.00